Published: 1 March 2019
Author(s): Charlotte Andersson, Peter Wæde Hansen, Ida E. Steffensen, Charlotte Andreasen, Peter E. Weeke, Lars Køber, Gunnar H. Gislason, Christian Torp-Pedersen
Issue: March 2019
Section: Original Article

The optimal medical treatment in patients with chronic obstructive pulmonary disease (COPD) and right-sided heart failure (RHF) is unknown. We aimed to estimate the risks of all-cause mortality associated with the current clinical use of various cardiovascular drugs in this patient-group.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.